The Latest Cardiac and Vascular News
ASSURE System Honored as One of the Year’s Best Designed Cardiovascular Devices KIRKLAND, Wash.–(BUSINESS WIRE)–Kestra Medical Technologies announced today that the company’s ASSURE® Wearable Cardioverter Defibrillator (WCD) system was recognized as one of the winners of the(MDEA), garnering honors in the Cardiovascular Devices category. The ASSURE® WCD system represents the next generation of monitoring and […]
The company plans to develop Lilly’s first-in-class clinical stage anti-angiopoietin-like 3/8 monoclonal antibody for treatment of atherosclerotic cardiovascular disease and potentially other conditions OXFORD, England & CAMBRIDGE, Mass.–(BUSINESS WIRE)–Kyttaro announces that it has entered into an agreement for the worldwide exclusive license of an anti-angiopoietin-like (ANGPTL) 3/8 monoclonal antibody program […]
~ Acquisition brings highly differentiated, proprietary biomaterial technologies for implantable cardiovascular devices to enable our customers’ innovation ~ PLANO, Texas, April 07, 2022 (GLOBE NEWSWIRE) — Today, Integer Holdings Corporation (NYSE: ITGR) announced the acquisition of Connemara Biomedical Holdings Teoranta, including its operating subsidiaries Aran Biomedical and Proxy Biomedical (collectively […]
Fiscal 2022 Third Quarter Highlights Net sales of $74.0 million increased 3.9% compared to the prior-year quarter Med Tech grew 28.6% and Med Device declined 2.8% year over year Gross margin of 52.2% declined 190 basis points year over year GAAP loss per share of $0.13 and adjusted earnings per […]
Opportunities Featuring Proprietary Surface Coated Technologies CARLSBAD, Calif., April 7, 2022 /PRNewswire/ — CeloNova BioSciences, Inc. (CeloNova), developer and manufacturer of a portfolio of novel surfaced coated technologies, including the proprietary Polyzene™-F nanocoating, today announced the strategic decision to focus its core business on creating partnership and co-development opportunities with medical device manufacturers seeking […]
MONMOUTH JUNCTION, N.J., April 7, 2022 /PRNewswire/ — CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification, today announced that it has received approximately $740,000, net of transactions costs, in cash proceeds from the sale of its 2020 Net Operating Loss (NOL) and […]
NANJING, China, April 7, 2022 /PRNewswire/ — Triastek, Inc. (“Triastek”) recently announced that the United States Food and Drug Administration (FDA) has granted permission to begin clinical studies of its Investigational New Drug (IND) 505(b)(2) application for a 3D printed drug product – T20. It is Triastek’s second product receiving IND clearance from the […]
With this move, government hospitals across India can now access the geko™ device to prevent life threatening blood clots, address complications related to swelling following orthopaedic surgery and the healing of chronic wounds (leg ulcers). DARESBURY, England, April 6, 2022 /PRNewswire/ — Sky Medical Technology Ltd (Sky), a UK-based medical device manufacturer and parent company […]
Albany, N.Y., April 07, 2022 (GLOBE NEWSWIRE) — When we get sick, our number one goal is to feel better as fast as possible. When people have heart attacks, their number one goal is to ensure it never happens again. Cardiac rehab is one of the best methods a person […]
Receives eighth FDA clearance, releases its next-generation Cardio AI application SAN FRANCISCO, April 07, 2022 (GLOBE NEWSWIRE) — Arterys, the world’s leading vendor-neutral AI platform, has announced several new modules to its already robust Cardio AI clinical application and an additional FDA AI clearance based on deep learning. Cardio AI […]
